Comparison of the bronchodilating effects of inhaled β₂-agonists after methacholine challenge in a human lung reperfusion model

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Mirjam GnadtPetra Högger

Abstract

The aim of the present investigation was to compare the onset of action and intrinsic activity of the long-acting β(2)-agonist GW597901 with the fast- and short-acting salbutamol as model compounds using an isolated human lung reperfusion model. Twelve resected human lung lobes were challenged with methacholine (MCh) and subsequently nebulised with either GW597901 or salbutamol. Prostaglandin E(2) (PGE(2)) concentrations in the perfusion fluid were compared with the dose of MCh that was required to induce a bronchoconstriction. After successful MCh provocation, nebulisation of GW597901 and salbutamol fully reversed any observed bronchoconstriction. The bronchodilating effect was more pronounced for GW597901. Salbutamol revealed an immediate onset of action while the effect of GW597901 was observed with an approximate delay of 6 min. Higher doses of MCh were required for a successful bronchial challenge in the presence of elevated PGE(2) levels (r=0.8171, p ≤ 0.05). For the first time, an isolated perfused human lung model has been established for comparing the onset of action and potency of a short- and long-acting β(2)-agonist. We therefore conclude that it is an alternative for determination of drug effect characteristics and...Continue Reading

References

Oct 1, 1994·American Journal of Respiratory and Critical Care Medicine·R E KannerR A Wise
Jun 1, 1996·The Thoracic and Cardiovascular Surgeon·A LinderH Toomes
Jan 1, 1997·Critical Reviews in Therapeutic Drug Carrier Systems·J Yu, Y W Chien
Nov 17, 1998·American Journal of Respiratory and Critical Care Medicine·A D Fryer, D B Jacoby
Aug 31, 2002·Respiratory Medicine·A WoodcockG Poli
Jan 10, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Bahman AsgharianEarl W Tewksbury
Oct 23, 2003·Analytical Chemistry·Paul H C Eilers
Feb 15, 2005·Pulmonary Pharmacology & Therapeutics·Carsten EhrhardtUdo Bakowsky
Mar 15, 2005·Archives of Physiology and Biochemistry·N B CharanL J Ashworth
Jul 19, 2005·Expert Opinion on Investigational Drugs·Mario CazzolaJan Lötvall
Aug 23, 2005·Proceedings of the American Thoracic Society·Diana C Grootendorst, Klaus F Rabe
Aug 23, 2005·Proceedings of the American Thoracic Society·Peter J Barnes
Sep 4, 2007·Lancet·A Sonia BuistUNKNOWN BOLD Collaborative Research Group
Jan 2, 2008·The European Respiratory Journal·E D BatemanH J Zar
Dec 2, 2009·Journal of Pharmaceutical Sciences·Cynthia Bosquillon
Aug 10, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Elizabeth M RosethorneSteven J Charlton

❮ Previous
Next ❯

Citations

Jan 9, 2013·Expert Opinion on Drug Metabolism & Toxicology·Xin LiuMichael S Roberts
Sep 28, 2007·Ecotoxicology and Environmental Safety·Tamara CojaErwin Meyer
Aug 10, 2019·Pharmaceutics·Johanna J SalomonCarsten Ehrhardt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.